TH124135A - - Google Patents

Info

Publication number
TH124135A
TH124135A TH801005666A TH0801005666A TH124135A TH 124135 A TH124135 A TH 124135A TH 801005666 A TH801005666 A TH 801005666A TH 0801005666 A TH0801005666 A TH 0801005666A TH 124135 A TH124135 A TH 124135A
Authority
TH
Thailand
Prior art keywords
estradiol
lactose
levonorgestrel
pharmaceuticals
beta
Prior art date
Application number
TH801005666A
Other languages
English (en)
Thai (th)
Original Assignee
นายจักรพรรดิ์ มงคลสิทธิ์ นางสาวปรับโยชน์ ศรีกิจจาภรณ์ นายรุทร นพคุณ
Filing date
Publication date
Application filed by นายจักรพรรดิ์ มงคลสิทธิ์ นางสาวปรับโยชน์ ศรีกิจจาภรณ์ นายรุทร นพคุณ filed Critical นายจักรพรรดิ์ มงคลสิทธิ์ นางสาวปรับโยชน์ ศรีกิจจาภรณ์ นายรุทร นพคุณ
Publication of TH124135A publication Critical patent/TH124135A/th

Links

TH801005666A 2008-11-03 TH124135A (pt)

Publications (1)

Publication Number Publication Date
TH124135A true TH124135A (pt) 2013-05-31

Family

ID=

Similar Documents

Publication Publication Date Title
Schindler The “newer” progestogens and postmenopausal hormone therapy (HRT)
Africander et al. Molecular mechanisms of steroid receptor-mediated actions by synthetic progestins used in HRT and contraception
Chai et al. Migraine and estrogen
Sitruk-Ware Hormonal contraception and thrombosis
Ruan et al. The pharmacology of nomegestrol acetate
McCormack Dienogest: a review of its use in the treatment of endometriosis
JP2019163318A5 (pt)
Sweeney et al. Molecular modulation of estrogen-induced apoptosis by synthetic progestins in hormone replacement therapy: an insight into the women's health initiative study
AR082998A1 (es) Asociacion farmaceutica para tratar y/o prevenir mioma y/o endometriosis, uso de resveratrol y progestogeno, composicion farmaceutica para tratamiento y/o prevencion de mioma y/o endometriosis, medicamento para tratamiento y/o prevencion de mioma y/o endometriosis, kit y metodo para tratamiento y/o prevencion de mioma y/o endometriosis
Mueck et al. Choice of progestogen for endometrial protection in combination with transdermal estradiol in menopausal women
ATE493132T1 (de) Arzneimittel umfassend wenigstens ein gestagen
BRPI0713565B1 (pt) processo para fabricação de uma forma de dosagem oral sólida
NO20022292L (no) Nye topiske östrogenprogestogenpreparater med systemisk effekt
Raps et al. Resistance to APC and SHBG levels during use of a four-phasic oral contraceptive containing dienogest and estradiol valerate: a randomized controlled trial
RU2007148080A (ru) Составы и способы для лечения симптомов, связанных с циклом
Cagnacci Hormonal contraception: venous and arterial disease
London et al. Rationale for eliminating the hormone-free interval in modern oral contraceptives
Guerra et al. Progestins in combined contraceptives
JP2010539153A5 (pt)
WO2005077968A8 (en) 17-methylene-or 17 - spiro - cyclopropane 7 - substituted estra - 1, 3, 5 (10) - triene derivatives with anti - estrogenic activity
JP2008515909A5 (pt)
AR054245A1 (es) Oblea que contiene hormonas esteroides
JP2008534533A5 (pt)
Kaunitz Enhancing oral contraceptive success: the potential of new formulations
EP1857111A3 (en) Composition comprising a combination of an aromatase inhibitor, a progestin and an estrogen, and its use for the treatment of endometriosis